Back to TCRX
DC Funds, LP TCRX Position History
TScan Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$198.1M
Q3 2026
Peak value
$630M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $630M |
| Q1 2026 | $630M |
| Q2 2026 | $617.5M |
| Q3 2026 | $198.1M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $198.1M | 630.0K | — | — |
| Q2 2026 | $617.5M | 630.0K | — | — |
| Q1 2026 | $630M | 630.0K | — | — |
| Q4 2025 | $630M | 630.0K | — | — |